Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Kelly Maloney

Concepts (374)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
40
2025
293
5.620
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
11
2025
86
1.660
Why?
Antineoplastic Combined Chemotherapy Protocols
18
2026
1938
1.250
Why?
Down Syndrome
6
2023
523
1.230
Why?
Burkitt Lymphoma
3
2024
63
0.930
Why?
Leukemia, Myeloid, Acute
7
2026
674
0.880
Why?
Asparaginase
8
2020
30
0.840
Why?
Fishes
1
2024
110
0.810
Why?
Agriculture
1
2024
102
0.790
Why?
Child
74
2026
22440
0.740
Why?
Bayes Theorem
1
2024
427
0.720
Why?
Consolidation Chemotherapy
2
2019
10
0.660
Why?
Neoplasm Recurrence, Local
6
2025
1123
0.620
Why?
Child, Preschool
49
2026
11630
0.610
Why?
Ecosystem
1
2024
585
0.580
Why?
Disease-Free Survival
12
2024
767
0.550
Why?
Leukemia
4
2021
246
0.540
Why?
Oncogene Proteins, Fusion
6
2024
210
0.530
Why?
Mercaptopurine
5
2017
15
0.510
Why?
Prognosis
17
2026
4210
0.510
Why?
Infant
36
2026
9885
0.460
Why?
Recurrence
12
2025
1122
0.460
Why?
Antineoplastic Agents
7
2019
2220
0.460
Why?
Preleukemia
1
2015
2
0.450
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
2016
128
0.440
Why?
Drug Hypersensitivity
3
2017
92
0.430
Why?
Molecular Targeted Therapy
3
2021
440
0.420
Why?
Leukemia, Monocytic, Acute
1
2014
3
0.420
Why?
Sarcoma, Myeloid
1
2014
4
0.420
Why?
Neoplasm, Residual
7
2023
135
0.400
Why?
Adolescent
42
2026
22233
0.400
Why?
Bone Marrow Transplantation
1
2014
294
0.380
Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
2023
26
0.370
Why?
Erwinia
2
2020
3
0.360
Why?
Medical Oncology
5
2025
327
0.360
Why?
Humans
86
2026
143821
0.350
Why?
Tumor Suppressor Proteins
3
1999
324
0.350
Why?
Chromosome Aberrations
2
2022
164
0.350
Why?
Acute Kidney Injury
1
2019
848
0.340
Why?
Neutropenia
2
2022
155
0.340
Why?
Male
58
2026
71569
0.330
Why?
Hematopoietic Stem Cell Transplantation
2
2019
681
0.330
Why?
Stem Cell Transplantation
3
2019
190
0.320
Why?
Rhabdomyosarcoma
1
2011
63
0.320
Why?
Cell Cycle Proteins
3
1999
636
0.310
Why?
Carrier Proteins
3
1999
750
0.310
Why?
Sarcoma, Ewing
1
2011
101
0.310
Why?
Biomarkers, Tumor
3
2026
1327
0.300
Why?
Ploidies
2
2019
20
0.300
Why?
Lymphoma, Large B-Cell, Diffuse
2
2022
193
0.290
Why?
Core Binding Factor Alpha 2 Subunit
3
2021
31
0.290
Why?
Genes, Tumor Suppressor
2
1999
90
0.280
Why?
Catheter-Related Infections
2
2022
93
0.280
Why?
Survival Rate
8
2024
2034
0.280
Why?
Cyclophosphamide
4
2019
267
0.280
Why?
Female
56
2026
77570
0.280
Why?
Catheterization, Central Venous
2
2022
120
0.270
Why?
Philadelphia Chromosome
2
2018
18
0.270
Why?
Medication Adherence
3
2017
519
0.260
Why?
Gene Deletion
2
1998
388
0.240
Why?
Vincristine
4
2021
138
0.240
Why?
Neoplasm Proteins
2
2018
443
0.230
Why?
Trisomy
2
2021
78
0.230
Why?
Antimetabolites, Antineoplastic
2
2017
107
0.230
Why?
Etoposide
2
2019
166
0.230
Why?
Ikaros Transcription Factor
1
2025
24
0.220
Why?
Young Adult
15
2024
13914
0.210
Why?
Maryland
1
2024
63
0.210
Why?
Invertebrates
1
2024
24
0.210
Why?
Cyclin-Dependent Kinase Inhibitor p16
3
1999
89
0.210
Why?
Rivers
1
2024
67
0.210
Why?
Treatment Outcome
12
2023
11459
0.200
Why?
PAX5 Transcription Factor
2
2024
14
0.200
Why?
Anxiety
3
2016
1100
0.200
Why?
Polymorphism, Single Nucleotide
4
2025
2167
0.190
Why?
Genomics
4
2025
834
0.190
Why?
Gene Rearrangement
3
2019
156
0.180
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2023
78
0.180
Why?
Leukemia, Myelomonocytic, Juvenile
1
2022
4
0.180
Why?
Polyethylene Glycols
5
2020
638
0.180
Why?
Induction Chemotherapy
2
2019
86
0.180
Why?
Health Equity
1
2024
119
0.180
Why?
Central Venous Catheters
1
2022
53
0.170
Why?
Environmental Monitoring
1
2024
377
0.170
Why?
Prednisone
2
2019
223
0.170
Why?
Program Evaluation
2
2017
947
0.170
Why?
Lymphoma
1
2023
234
0.170
Why?
Doxorubicin
2
2022
395
0.170
Why?
Lung Neoplasms
1
2014
2636
0.160
Why?
Adult
23
2023
40129
0.160
Why?
Translocation, Genetic
2
2013
115
0.160
Why?
Maintenance Chemotherapy
2
2017
42
0.160
Why?
Bacterial Infections
1
2022
247
0.160
Why?
Immunocompromised Host
1
2021
201
0.150
Why?
Diploidy
1
2019
16
0.150
Why?
Risk Factors
11
2022
10623
0.150
Why?
Genes, p16
1
1999
13
0.150
Why?
Hyperglycemia
1
2023
370
0.140
Why?
Chromosomes, Human, Pair 19
1
1998
27
0.140
Why?
Quality of Life
3
2024
3142
0.140
Why?
Chromosomes, Human, Pair 17
1
1998
55
0.140
Why?
Myelodysplastic Syndromes
1
2020
143
0.140
Why?
Antibodies, Bispecific
1
2019
64
0.140
Why?
Rituximab
1
2019
210
0.140
Why?
Chromosomes, Human, Pair 1
1
1998
76
0.140
Why?
Prospective Studies
9
2022
7900
0.140
Why?
Mutagenesis
1
1999
191
0.140
Why?
Prostate-Specific Antigen
2
2009
158
0.140
Why?
Substance Withdrawal Syndrome
1
2020
184
0.130
Why?
Patient Safety
1
2021
338
0.130
Why?
Proto-Oncogenes
1
1997
29
0.130
Why?
Family Relations
2
2016
94
0.130
Why?
Thioguanine
1
2017
18
0.130
Why?
Thionucleotides
1
2017
35
0.130
Why?
Apyrase
1
2017
27
0.130
Why?
Oncologists
1
2017
46
0.130
Why?
Blast Crisis
1
2016
35
0.120
Why?
Follow-Up Studies
6
2021
5316
0.120
Why?
Carboxypeptidases A
1
2016
2
0.120
Why?
Pediatricians
1
2017
122
0.120
Why?
Gene Expression Regulation, Enzymologic
1
2017
273
0.120
Why?
Sepsis
1
2022
639
0.120
Why?
Adrenal Cortex Hormones
1
2019
500
0.120
Why?
Osteonecrosis
1
2015
23
0.120
Why?
Retrospective Studies
10
2023
16754
0.110
Why?
Nausea
1
2016
111
0.110
Why?
Mentors
2
2017
214
0.110
Why?
Depression
2
2016
1520
0.110
Why?
Cohort Studies
6
2026
5861
0.110
Why?
Pancreatitis
1
2016
135
0.110
Why?
Central Nervous System Neoplasms
1
2017
172
0.110
Why?
Dexamethasone
4
2021
373
0.110
Why?
Monitoring, Physiologic
1
2017
291
0.110
Why?
Fusion Proteins, bcr-abl
2
2016
69
0.110
Why?
Mentoring
1
2017
162
0.110
Why?
Longitudinal Studies
7
2016
2948
0.110
Why?
Mutation
4
2022
4106
0.110
Why?
Cyclin-Dependent Kinase Inhibitor p15
3
1999
14
0.110
Why?
Myeloid-Lymphoid Leukemia Protein
2
2010
71
0.110
Why?
High-Throughput Nucleotide Sequencing
1
2017
559
0.100
Why?
Bacteremia
1
2016
220
0.100
Why?
Repressor Proteins
1
1997
432
0.100
Why?
Flow Cytometry
1
2018
1192
0.100
Why?
Antigens, CD
1
2017
564
0.100
Why?
Cross Infection
1
2016
260
0.100
Why?
Pediatrics
3
2021
1080
0.100
Why?
Life Change Events
1
2014
146
0.100
Why?
Chromosomes, Human, Pair 21
1
2013
42
0.100
Why?
DNA-Binding Proteins
2
1998
1493
0.100
Why?
Histone-Lysine N-Methyltransferase
2
2010
140
0.100
Why?
Risk Assessment
5
2026
3556
0.100
Why?
Immunotherapy
1
2018
669
0.100
Why?
Leukemia, Megakaryoblastic, Acute
1
2012
10
0.090
Why?
Transcription Factors
2
1998
1735
0.090
Why?
Venous Thromboembolism
1
2017
330
0.090
Why?
Myeloproliferative Disorders
1
2012
19
0.090
Why?
Karyotyping
3
2019
107
0.090
Why?
Quality Improvement
1
2021
1268
0.090
Why?
Self Report
1
2017
865
0.090
Why?
Contraindications
1
2012
84
0.090
Why?
Arabinonucleosides
1
2011
8
0.090
Why?
Adenine Nucleotides
1
2011
21
0.090
Why?
Prostatic Neoplasms
2
2009
977
0.090
Why?
Antibodies, Monoclonal
1
2018
1522
0.080
Why?
Chromosomes, Human, Pair 10
1
2010
19
0.080
Why?
Chromosomes, Human, Pair 4
1
2010
27
0.080
Why?
Pain
1
2016
776
0.080
Why?
Multivariate Analysis
4
2015
1508
0.080
Why?
T-Lymphocytes
1
2018
2041
0.070
Why?
Parents
2
2016
1414
0.070
Why?
Age Factors
8
2019
3288
0.070
Why?
Prostatectomy
1
2009
89
0.070
Why?
Bloom Syndrome
1
1988
3
0.070
Why?
Neoplasm Metastasis
1
2011
704
0.070
Why?
Juxtaglomerular Apparatus
1
2007
2
0.070
Why?
Gene Expression Regulation, Leukemic
2
2016
55
0.070
Why?
Polymerase Chain Reaction
1
2010
1057
0.060
Why?
Drug Administration Schedule
2
2017
779
0.060
Why?
Blood Coagulation
1
2008
272
0.060
Why?
Clinical Trials, Phase III as Topic
1
2026
118
0.060
Why?
Clinical Trials as Topic
2
2024
1047
0.060
Why?
Stress, Psychological
1
2014
1147
0.060
Why?
Surveys and Questionnaires
4
2024
6004
0.060
Why?
Animals
3
2024
38140
0.060
Why?
Methotrexate
2
2017
239
0.060
Why?
Remission Induction
2
2019
307
0.050
Why?
Acute Disease
2
2019
996
0.050
Why?
Case-Control Studies
3
2024
3614
0.050
Why?
Selection Bias
1
2024
38
0.050
Why?
Personal Satisfaction
2
2017
221
0.050
Why?
Incidence
3
2019
2845
0.050
Why?
Administration, Oral
2
2017
841
0.050
Why?
Genetic Variation
1
1988
990
0.050
Why?
Kidney Neoplasms
1
2007
410
0.050
Why?
Risk
5
2023
901
0.050
Why?
Drug Monitoring
2
2017
394
0.050
Why?
Disease Progression
2
2021
2871
0.050
Why?
Proto-Oncogene Proteins c-cbl
1
2022
13
0.040
Why?
Randomized Controlled Trials as Topic
2
2020
1688
0.040
Why?
Exome
1
2022
239
0.040
Why?
Drug Therapy
1
2021
81
0.040
Why?
Menorrhagia
1
2001
22
0.040
Why?
Transcriptome
2
2019
1047
0.040
Why?
Diarrhea
2
1999
188
0.040
Why?
Bone Marrow
1
2022
303
0.040
Why?
Endocrine Glands
1
1979
14
0.040
Why?
Blood Cell Count
1
1999
53
0.040
Why?
Chromosomes, Human
1
2019
44
0.040
Why?
Cytogenetic Analysis
1
2019
33
0.040
Why?
Azacitidine
1
2020
154
0.040
Why?
Loss of Heterozygosity
1
1999
52
0.040
Why?
Viral Load
1
2021
515
0.040
Why?
Genome-Wide Association Study
2
2016
1446
0.040
Why?
Mosaicism
1
2019
75
0.040
Why?
Sequence Deletion
1
1999
194
0.040
Why?
Hypertension
1
2007
1239
0.040
Why?
Disinfectants
1
1999
47
0.040
Why?
National Cancer Institute (U.S.)
1
2018
52
0.040
Why?
Chromosomes
1
2019
107
0.030
Why?
Bridged Bicyclo Compounds, Heterocyclic
1
2020
272
0.030
Why?
Escherichia coli O157
1
1998
35
0.030
Why?
Infant, Newborn
4
2019
6362
0.030
Why?
Methylation
1
1998
243
0.030
Why?
Overweight
1
2023
598
0.030
Why?
Biopsy
1
2021
1068
0.030
Why?
Interviews as Topic
1
2021
884
0.030
Why?
Community Participation
1
1999
134
0.030
Why?
United States
4
2021
15602
0.030
Why?
Genetic Predisposition to Disease
2
2017
2407
0.030
Why?
Erythrocyte Count
1
2017
21
0.030
Why?
Glucose
1
2023
1041
0.030
Why?
Public Health Surveillance
1
2017
83
0.030
Why?
Escherichia coli Infections
1
1998
128
0.030
Why?
Food-Drug Interactions
1
2017
11
0.030
Why?
Injections, Intramuscular
1
2017
135
0.030
Why?
Proto-Oncogene Proteins c-ets
1
1997
56
0.030
Why?
Career Mobility
1
2017
70
0.030
Why?
Leucovorin
1
2017
100
0.030
Why?
Dairy Products
1
2017
30
0.030
Why?
Cerebrospinal Fluid
1
2017
92
0.030
Why?
MEF2 Transcription Factors
1
2016
51
0.030
Why?
Family
1
2021
692
0.030
Why?
Cranial Irradiation
1
2017
85
0.030
Why?
Water Purification
1
1999
157
0.030
Why?
Infusions, Intravenous
1
2017
427
0.030
Why?
Leukocyte Count
1
2017
317
0.030
Why?
Luciferases
1
2016
153
0.030
Why?
Methyltransferases
1
2017
74
0.030
Why?
NIH 3T3 Cells
1
2016
151
0.030
Why?
Feasibility Studies
1
2021
1065
0.030
Why?
Sulfonamides
1
2020
574
0.030
Why?
Ethers
1
1996
19
0.030
Why?
Methyl Ethers
1
1996
19
0.030
Why?
Bone Morphogenetic Protein 7
1
2015
12
0.030
Why?
Fluorides
1
1996
49
0.030
Why?
Hemorrhage
1
2001
799
0.030
Why?
Cytarabine
1
2016
66
0.030
Why?
Genotype
3
2017
1837
0.030
Why?
Health Education
1
1999
358
0.030
Why?
Anesthetics, Inhalation
1
1996
51
0.030
Why?
Severity of Illness Index
2
2017
2926
0.030
Why?
Breast Neoplasms
5
1979
2497
0.030
Why?
Spinal Dysraphism
1
1996
107
0.030
Why?
Histone Deacetylase Inhibitors
1
2016
219
0.030
Why?
Disease Management
1
2019
639
0.030
Why?
Middle Aged
10
2019
35630
0.030
Why?
Alternative Splicing
1
2017
243
0.030
Why?
Homeodomain Proteins
1
1998
524
0.030
Why?
HEK293 Cells
1
2017
748
0.030
Why?
Promoter Regions, Genetic
1
1999
1255
0.030
Why?
Sequence Analysis, RNA
1
2016
445
0.030
Why?
Intensive Care Units, Pediatric
1
2016
281
0.030
Why?
DNA Methylation
1
1999
673
0.030
Why?
Qualitative Research
1
2021
1626
0.030
Why?
Psychomotor Agitation
1
2014
45
0.030
Why?
Behavior
1
2014
90
0.020
Why?
Demography
1
2014
289
0.020
Why?
Income
1
2014
197
0.020
Why?
Marriage
1
2014
122
0.020
Why?
Algorithms
1
2021
1843
0.020
Why?
Base Sequence
1
2016
2186
0.020
Why?
Aged
9
2019
25615
0.020
Why?
Blood Glucose
1
2023
2325
0.020
Why?
Odds Ratio
1
2015
1057
0.020
Why?
In Situ Hybridization, Fluorescence
1
2013
321
0.020
Why?
Aggression
1
2014
179
0.020
Why?
Prevalence
2
2016
2819
0.020
Why?
Nucleoside Transport Proteins
1
2011
8
0.020
Why?
Kidney
2
1996
1483
0.020
Why?
Regression Analysis
1
2014
1003
0.020
Why?
Antineoplastic Agents, Alkylating
1
2011
70
0.020
Why?
Time Factors
2
2015
7068
0.020
Why?
Erythrocytes
1
2017
757
0.020
Why?
Escherichia coli
1
2015
849
0.020
Why?
Antineoplastic Agents, Phytogenic
1
2011
179
0.020
Why?
Mice
2
2019
18421
0.020
Why?
Survival Analysis
1
2013
1358
0.020
Why?
Logistic Models
1
2015
2095
0.020
Why?
Bacteria
1
2016
888
0.020
Why?
Obesity
1
2023
3073
0.020
Why?
Kaplan-Meier Estimate
1
2011
957
0.020
Why?
Sister Chromatid Exchange
1
1988
4
0.020
Why?
Genetic Complementation Test
1
1988
67
0.020
Why?
Cell Fusion
1
1988
49
0.020
Why?
Emotions
1
2014
575
0.020
Why?
Plasminogen Activator Inhibitor 1
1
2008
85
0.020
Why?
Water Microbiology
2
1999
88
0.020
Why?
Protein C
1
2008
54
0.020
Why?
Antithrombins
1
2008
70
0.020
Why?
Mice, Inbred C57BL
1
2019
6032
0.020
Why?
Genetic Markers
1
1988
338
0.020
Why?
Fibrinogen
1
2008
180
0.020
Why?
Renin-Angiotensin System
1
2007
78
0.020
Why?
Transplantation, Homologous
1
2008
414
0.020
Why?
Biopsy, Needle
1
2007
184
0.020
Why?
Rare Diseases
1
2007
113
0.020
Why?
Blood Pressure Determination
1
2007
141
0.020
Why?
Nephrectomy
1
2007
156
0.020
Why?
Biomarkers
1
2017
4248
0.010
Why?
RNA, Messenger
1
2011
2847
0.010
Why?
Immunohistochemistry
1
2007
1733
0.010
Why?
Cell Line
1
1988
2906
0.010
Why?
Anemia, Hypochromic
1
2001
2
0.010
Why?
Blood Platelet Disorders
1
2001
10
0.010
Why?
von Willebrand Diseases
1
2001
29
0.010
Why?
Estriol
1
1979
6
0.010
Why?
Estrone
1
1979
40
0.010
Why?
Menstruation
1
1979
41
0.010
Why?
Prolactin
1
1979
92
0.010
Why?
Thrombocytopenia
1
2001
208
0.010
Why?
Bolivia
1
1999
61
0.010
Why?
Luteinizing Hormone
1
1979
191
0.010
Why?
Follicle Stimulating Hormone
1
1979
250
0.010
Why?
Restaurants
1
1998
22
0.010
Why?
Swimming
1
1998
49
0.010
Why?
Food Handling
1
1998
63
0.010
Why?
Progesterone
1
1979
255
0.010
Why?
Disease Transmission, Infectious
1
1998
68
0.010
Why?
Water Supply
1
1998
88
0.010
Why?
Meat
1
1998
92
0.010
Why?
Kyphosis
1
1996
37
0.010
Why?
Halothane
1
1996
7
0.010
Why?
Analysis of Variance
1
1999
1308
0.010
Why?
Estradiol
1
1979
538
0.010
Why?
Congenital Abnormalities
1
1996
105
0.010
Why?
Population Surveillance
1
1999
491
0.010
Why?
Feces
1
1998
506
0.010
Why?
Diagnostic Imaging
1
1996
334
0.010
Why?
Ovarian Neoplasms
1
1978
594
0.010
Why?
Pedigree
3
1978
512
0.010
Why?
Nebraska
2
1976
20
0.000
Why?
Aged, 80 and over
1
1999
8130
0.000
Why?
New York
2
1976
125
0.000
Why?
Genes
1
1978
226
0.000
Why?
Genetic Linkage
1
1978
274
0.000
Why?
Oncogenic Viruses
1
1976
3
0.000
Why?
Apocrine Glands
1
1976
4
0.000
Why?
Genetic Techniques
1
1976
67
0.000
Why?
Pheochromocytoma
1
1976
58
0.000
Why?
Statistics as Topic
1
1976
279
0.000
Why?
Syndrome
1
1976
373
0.000
Why?
Klinefelter Syndrome
1
1976
76
0.000
Why?
HLA Antigens
1
1976
227
0.000
Why?
Skin Diseases
1
1976
149
0.000
Why?
Abnormalities, Multiple
1
1976
196
0.000
Why?
Pregnancy
2
1978
7154
0.000
Why?
Sarcoma
1
1976
203
0.000
Why?
Sex Factors
1
1978
2078
0.000
Why?
Thyroid Neoplasms
1
1976
346
0.000
Why?
Neoplasms
2
1976
2902
0.000
Why?
Melanoma
1
1976
806
0.000
Why?
Phenotype
1
1976
3183
0.000
Why?
Registries
1
1976
2242
0.000
Why?
Brain Neoplasms
1
1976
1307
0.000
Why?
Maloney's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)